Cargando…

Intralesional rituximab for cutaneous manifestations of systemic B-cell lymphoma

Detalles Bibliográficos
Autores principales: Maillet-Lebel, Nicole, Thibeault, Marie-Marthe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992004/
https://www.ncbi.nlm.nih.gov/pubmed/27570817
http://dx.doi.org/10.1016/j.jdcr.2016.07.006
_version_ 1782448933097701376
author Maillet-Lebel, Nicole
Thibeault, Marie-Marthe
author_facet Maillet-Lebel, Nicole
Thibeault, Marie-Marthe
author_sort Maillet-Lebel, Nicole
collection PubMed
description
format Online
Article
Text
id pubmed-4992004
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-49920042016-08-26 Intralesional rituximab for cutaneous manifestations of systemic B-cell lymphoma Maillet-Lebel, Nicole Thibeault, Marie-Marthe JAAD Case Rep Case Report Elsevier 2016-08-17 /pmc/articles/PMC4992004/ /pubmed/27570817 http://dx.doi.org/10.1016/j.jdcr.2016.07.006 Text en © 2016 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Maillet-Lebel, Nicole
Thibeault, Marie-Marthe
Intralesional rituximab for cutaneous manifestations of systemic B-cell lymphoma
title Intralesional rituximab for cutaneous manifestations of systemic B-cell lymphoma
title_full Intralesional rituximab for cutaneous manifestations of systemic B-cell lymphoma
title_fullStr Intralesional rituximab for cutaneous manifestations of systemic B-cell lymphoma
title_full_unstemmed Intralesional rituximab for cutaneous manifestations of systemic B-cell lymphoma
title_short Intralesional rituximab for cutaneous manifestations of systemic B-cell lymphoma
title_sort intralesional rituximab for cutaneous manifestations of systemic b-cell lymphoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992004/
https://www.ncbi.nlm.nih.gov/pubmed/27570817
http://dx.doi.org/10.1016/j.jdcr.2016.07.006
work_keys_str_mv AT mailletlebelnicole intralesionalrituximabforcutaneousmanifestationsofsystemicbcelllymphoma
AT thibeaultmariemarthe intralesionalrituximabforcutaneousmanifestationsofsystemicbcelllymphoma